Shanghai Medicilon Inc. 688202.SS Stock
Shanghai Medicilon Inc. Price Chart
Shanghai Medicilon Inc. 688202.SS Financial and Trading Overview
Shanghai Medicilon Inc. stock price | 36.7 CNY |
Previous Close | 92.77 CNY |
Open | 93 CNY |
Bid | 93.36 CNY x N/A |
Ask | 93.37 CNY x N/A |
Day's Range | 92.01 - 94.86 CNY |
52 Week Range | 87.51 - 292.08 CNY |
Volume | 2.03M CNY |
Avg. Volume | 2.38M CNY |
Market Cap | 11.37B CNY |
Beta (5Y Monthly) | 0.599759 |
PE Ratio (TTM) | 29.735668 |
EPS (TTM) | 1.42 CNY |
Forward Dividend & Yield | 0.39 (0.44%) |
Ex-Dividend Date | June 2, 2023 |
1y Target Est | N/A |
688202.SS Valuation Measures
Enterprise Value | 11.47B CNY |
Trailing P/E | 29.735668 |
Forward P/E | 6.497565 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 6.483691 |
Price/Book (mrq) | 6.6721454 |
Enterprise Value/Revenue | 6.537 |
Enterprise Value/EBITDA | 27.763 |
Trading Information
Shanghai Medicilon Inc. Stock Price History
Beta (5Y Monthly) | 0.599759 |
52-Week Change | -52.37% |
S&P500 52-Week Change | 20.43% |
52 Week High | 292.08 CNY |
52 Week Low | 87.51 CNY |
50-Day Moving Average | 105.17 CNY |
200-Day Moving Average | 139.53 CNY |
688202.SS Share Statistics
Avg. Volume (3 month) | 2.38M CNY |
Avg. Daily Volume (10-Days) | 1.6M CNY |
Shares Outstanding | 121.82M |
Float | 51.62M |
Short Ratio | N/A |
% Held by Insiders | 57.01% |
% Held by Institutions | 25.11% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.279 |
Trailing Annual Dividend Yield | 0.30% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.32849997 |
Last Split Factor | 1.4:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 20.66% |
Operating Margin (ttm) | 19.95% |
Gross Margin | 41.16% |
EBITDA Margin | 23.54% |
Management Effectiveness
Return on Assets (ttm) | 10.08% |
Return on Equity (ttm) | 23.29% |
Income Statement
Revenue (ttm) | 1.75B CNY |
Revenue Per Share (ttm) | 14.41 CNY |
Quarterly Revenue Growth (yoy) | 26.80% |
Gross Profit (ttm) | 1.7B CNY |
EBITDA | 413.08M CNY |
Net Income Avi to Common (ttm) | 362.61M CNY |
Diluted EPS (ttm) | 3.14 |
Quarterly Earnings Growth (yoy) | 31.60% |
Balance Sheet
Total Cash (mrq) | 163.62M CNY |
Total Cash Per Share (mrq) | 1.34 CNY |
Total Debt (mrq) | 330.34M CNY |
Total Debt/Equity (mrq) | 19.38 CNY |
Current Ratio (mrq) | 1.776 |
Book Value Per Share (mrq) | 13.994 |
Cash Flow Statement
Operating Cash Flow (ttm) | 12.2M CNY |
Levered Free Cash Flow (ttm) | -550316928 CNY |
Profile of Shanghai Medicilon Inc.
Country | China |
State | N/A |
City | Shanghai |
Address | 585 Chuanda Road |
ZIP | 201299 |
Phone | 86 21 5859 1500 |
Website | https://www.medicilon.com.cn |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 3298 |
Shanghai Medicilon Inc., a drug discovery contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. It offers chemistry services, including medicinal, synthesis, and analytical chemistry services, as well as process development services; and drug formulation services, such as pre-formulation and analytical development services, as well as research on quality control and clinical trial material services. The company also provides biology services comprising recombinant protein, crystallization and structural, discovery biology, computational biology and molecular modeling, and kinase services, as well as prepackaged M9 selenomethionine growth media kits and packages for growing cell culture in IPTG-inducible bacterial expression systems. In addition, it offers pharmacology services, including cancer xenograft, metabolic disease, inflammation and immunological, neurological disorders, and other disease models; services in the areas of in vitro ADME and in vivo pharmacokinetics; and bioanalytical services, such as large and small molecule services. Further, the company provides preclinical services comprising preclinical pharmacokinetic and safety evaluation. Shanghai Medicilon Inc. was founded in 2004 and is headquartered in Shanghai, China.
Q&A For Shanghai Medicilon Inc. Stock
What is a current 688202.SS stock price?
Shanghai Medicilon Inc. 688202.SS stock price today per share is 36.7 CNY.
How to purchase Shanghai Medicilon Inc. stock?
You can buy 688202.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Medicilon Inc.?
The stock symbol or ticker of Shanghai Medicilon Inc. is 688202.SS.
Which industry does the Shanghai Medicilon Inc. company belong to?
The Shanghai Medicilon Inc. industry is Biotechnology.
How many shares does Shanghai Medicilon Inc. have in circulation?
The max supply of Shanghai Medicilon Inc. shares is 134.67M.
What is Shanghai Medicilon Inc. Price to Earnings Ratio (PE Ratio)?
Shanghai Medicilon Inc. PE Ratio is 25.84507200 now.
What was Shanghai Medicilon Inc. earnings per share over the trailing 12 months (TTM)?
Shanghai Medicilon Inc. EPS is 1.42 CNY over the trailing 12 months.
Which sector does the Shanghai Medicilon Inc. company belong to?
The Shanghai Medicilon Inc. sector is Healthcare.